In 2022 alone, four different Indian companies have been issued what's called import alerts by the FDA in the United States. The government initially seemed to move very, very slowly, but has now indicated that it will start doing more thorough inspections of both of these firms. Neither of these firms have sold the particular cost of in India that may have slowed things down.